188 related articles for article (PubMed ID: 23836963)
1. A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications.
Kakade S; Mani G
Drug Des Devel Ther; 2013; 7():529-44. PubMed ID: 23836963
[TBL] [Abstract][Full Text] [Related]
2. Interaction of endothelial and smooth muscle cells with cobalt-chromium alloy surfaces coated with paclitaxel deposited self-assembled monolayers.
Lamichhane S; Lancaster S; Thiruppathi E; Mani G
Langmuir; 2013 Nov; 29(46):14254-64. PubMed ID: 24156365
[TBL] [Abstract][Full Text] [Related]
3. Vitamin-C delivery from CoCr alloy surfaces using polymer-free and polymer-based platforms for cardiovascular stent applications.
Thiruppathi E; Mani G
Langmuir; 2014 Jun; 30(21):6237-49. PubMed ID: 24832897
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression.
Steinfeld DS; Liu AP; Hsu SH; Chan YF; Stankus JJ; Pacetti SD; Tai JT
J Cardiovasc Pharmacol; 2012 Aug; 60(2):179-86. PubMed ID: 22561362
[TBL] [Abstract][Full Text] [Related]
5. Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
Ceresnakova M; Murray D; Soulimane T; Hudson SP
Eur J Pharmacol; 2021 Nov; 910():174490. PubMed ID: 34492283
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.
Kural MH; Wang J; Gui L; Yuan Y; Li G; Leiby KL; Quijano E; Tellides G; Saltzman WM; Niklason LE
Biomaterials; 2019 Aug; 212():28-38. PubMed ID: 31102854
[TBL] [Abstract][Full Text] [Related]
7. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
Parry TJ; Brosius R; Thyagarajan R; Carter D; Argentieri D; Falotico R; Siekierka J
Eur J Pharmacol; 2005 Nov; 524(1-3):19-29. PubMed ID: 16271360
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Liuzzo JP; Ambrose JA; Coppola JT
J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
[TBL] [Abstract][Full Text] [Related]
10. [Effects of paclitaxel combined with bone marrow stromal stem cells implantation on vascular endothelial repair and smooth muscle cells growth in vitro].
Wu XJ; Huang L; Zhou Q; Song YM; Li AM; Jin J; Yu XJ; Qin J; Zhao G
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):464-8. PubMed ID: 15932712
[TBL] [Abstract][Full Text] [Related]
11. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle cells orchestrate the endothelial cell response to flow and injury.
Balcells M; Martorell J; Olivé C; Santacana M; Chitalia V; Cardoso AA; Edelman ER
Circulation; 2010 May; 121(20):2192-9. PubMed ID: 20458015
[TBL] [Abstract][Full Text] [Related]
13. Pressure alters endothelial effects upon vascular smooth muscle cells by decreasing smooth muscle cell proliferation and increasing smooth muscle cell apoptosis.
Vouyouka AG; Jiang Y; Basson MD
Surgery; 2004 Aug; 136(2):282-90. PubMed ID: 15300192
[TBL] [Abstract][Full Text] [Related]
14. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
[TBL] [Abstract][Full Text] [Related]
16. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
18. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
[TBL] [Abstract][Full Text] [Related]
19. Effect of paclitaxel and mesenchymal stem cells seeding on ex vivo vascular endothelial repair and smooth muscle cells growth.
Wu X; Huang L; Zhou Q; Song Y; Li A; Wang H; Song M
J Cardiovasc Pharmacol; 2005 Dec; 46(6):779-86. PubMed ID: 16306802
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Combined Transcriptomes Identifies Gene Modules that Differentially Respond to Pathogenic Stimulation of Vascular Smooth Muscle and Endothelial Cells.
Pan X; Wang B; Yuan T; Zhang M; Kent KC; Guo LW
Sci Rep; 2018 Jan; 8(1):395. PubMed ID: 29321689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
